ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly

Research Site, Los Angeles, California, United States

Research Site, Los Angeles, California, United States

Research Site, Torrance, California, United States

Research Site, Aurora, Colorado, United States

Research Site, Boston, Massachusetts, United States

Research Site, Ann Arbor, Michigan, United States

Research Site, Las Vegas, Nevada, United States

Research Site, New York, New York, United States

Research Site, Portland, Oregon, United States

Research Site, CABA, Argentina

Research Site, Ciudad de Buenos Aires, Argentina

Research Site, Ciudad de Buenos Aires, Argentina

Research Site, Ciudad de Buenos Aires, Argentina

Research Site, Curitiba, Brazil

Research Site, Ribeirão Preto, Brazil

Research Site, Rio de Janeiro, Brazil

Research Site, São Paulo, Brazil

Research Site, Beijing, China

Research Site, Guangzhou, China

Research Site, Kunming, China

Research Site, Shanghai, China

Research Site, Copenhagen, Denmark

Research Site, Odense, Denmark

Research Site, Budapest, Hungary

Research Site, Budapest, Hungary

Research Site, Pécs, Hungary

Research Site, Szeged, Hungary

Research Site, Cona, Italy

Research Site, Genoa, Italy

Research Site, Messina, Italy

Research Site, Milan, Italy

Research Site, Naples, Italy

Research Site, Pisa, Italy

Research Site, Roma, Italy

Research Site, Kaunas, Lithuania

Research Site, Vilnius, Lithuania

Research Site, Leiden, Netherlands

Research Site, Rotterdam, Netherlands

Research Site, Bydgoszcz, Poland

Research Site, Gliwice, Poland

Research Site, Krakow, Poland

Research Site, Warsaw, Poland

Research Site, Wroclaw, Poland

Research Site, Bucharest, Romania

Research Site, Cluj-Napoca, Romania